Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott D Solomon

Showing results (601-610 of 1,211) with videos related to

Pageof 122
Sort By:
American Heart Journal|July 11, 2006
Extent of coronary artery disease as a predictor of outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or bothRajesh Janardhanan, Satish Kenchaiah, Eric J Velazquez, et al.
Circulation. Heart Failure|March 11, 2016
Impact of Spironolactone on Longitudinal Changes in Health-Related Quality of Life in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist TrialEldrin F Lewis, Hae-Young Kim, Brian Claggett, et al.
Journal of the American College of Cardiology|May 22, 2023
Angiotensin-Neprilysin Inhibition in Patients With Mildly Reduced or Preserved Ejection Fraction and Worsening Heart FailureRobert J Mentz, Jonathan H Ward, Adrian F Hernandez, et al.
European Journal of Heart Failure|May 15, 2026
Iron deficiency and risk of heart failure and cardiovascular events in CKD: Insights from the ASCEND-ND trialBrendon L Neuen, Henri Lu, Muthiah Vaduganathan, et al.
Diabetes Care|October 21, 2020
Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering TherapyKieran F Docherty, Pardeep S Jhund, Olof Bengtsson, et al.
Journal of the American College of Cardiology|June 3, 2004
Alcohol consumption and prognosis in patients with left ventricular systolic dysfunction after a myocardial infarctionDavid Aguilar, Hicham Skali, Lemuel A Moyé, et al.
American Heart Journal|July 6, 2010
Fatal myocardial rupture after acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALsartan In Acute myocardial iNfarcTion Trial (VALIANT)Faisal Shamshad, Satish Kenchaiah, Peter V Finn, et al.
International Journal of Cardiology|December 1, 2012
Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANTSally C Inglis, Judith Bebchuk, Sultan A Al-Suhaim, et al.
Circulation. Heart Failure|October 12, 2017
Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial FibrillationSøren Lund Kristensen, Pardeep S Jhund, Ulrik M Mogensen, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 4, 2014
Assessment of myocardial viability and left ventricular function in patients supported by a left ventricular assist deviceDeepak K Gupta, Hicham Skali, Jose Rivero, et al.
Pageof 122

Showing results (601-610 of 1,211) with videos related to

Sort By:
Pageof 122
American Heart Journal|July 11, 2006
Extent of coronary artery disease as a predictor of outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or bothRajesh Janardhanan, Satish Kenchaiah, Eric J Velazquez, et al.
Circulation. Heart Failure|March 11, 2016
Impact of Spironolactone on Longitudinal Changes in Health-Related Quality of Life in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist TrialEldrin F Lewis, Hae-Young Kim, Brian Claggett, et al.
Journal of the American College of Cardiology|May 22, 2023
Angiotensin-Neprilysin Inhibition in Patients With Mildly Reduced or Preserved Ejection Fraction and Worsening Heart FailureRobert J Mentz, Jonathan H Ward, Adrian F Hernandez, et al.
European Journal of Heart Failure|May 15, 2026
Iron deficiency and risk of heart failure and cardiovascular events in CKD: Insights from the ASCEND-ND trialBrendon L Neuen, Henri Lu, Muthiah Vaduganathan, et al.
Diabetes Care|October 21, 2020
Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering TherapyKieran F Docherty, Pardeep S Jhund, Olof Bengtsson, et al.
Journal of the American College of Cardiology|June 3, 2004
Alcohol consumption and prognosis in patients with left ventricular systolic dysfunction after a myocardial infarctionDavid Aguilar, Hicham Skali, Lemuel A Moyé, et al.
American Heart Journal|July 6, 2010
Fatal myocardial rupture after acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALsartan In Acute myocardial iNfarcTion Trial (VALIANT)Faisal Shamshad, Satish Kenchaiah, Peter V Finn, et al.
International Journal of Cardiology|December 1, 2012
Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANTSally C Inglis, Judith Bebchuk, Sultan A Al-Suhaim, et al.
Circulation. Heart Failure|October 12, 2017
Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial FibrillationSøren Lund Kristensen, Pardeep S Jhund, Ulrik M Mogensen, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 4, 2014
Assessment of myocardial viability and left ventricular function in patients supported by a left ventricular assist deviceDeepak K Gupta, Hicham Skali, Jose Rivero, et al.
Pageof 122